M E Risner

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. ncbi Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease
    M E Risner
    World Wide Development, Research and Development, GlaxoSmithKline, Research Triangle Park, NC 27709 3398, USA
    Pharmacogenomics J 6:246-54. 2006

Detail Information

Publications1

  1. ncbi Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease
    M E Risner
    World Wide Development, Research and Development, GlaxoSmithKline, Research Triangle Park, NC 27709 3398, USA
    Pharmacogenomics J 6:246-54. 2006
    ..These preliminary findings require confirmation in appropriate clinical studies...